- Home
- EH vs COGT Comparison
EH vs COGT Comparison
Compare EH & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EH
- COGT
- Stock Information
- Founded
- EH 2014
- COGT 2014
- Country
- EH China
- COGT United States
- Employees
- EH N/A
- COGT N/A
- Industry
- EH Military/Government/Technical
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- EH Industrials
- COGT Health Care
- Exchange
- EH Nasdaq
- COGT Nasdaq
- Market Cap
- EH 1.1B
- COGT 1.1B
- IPO Year
- EH 2019
- COGT 2018
- Fundamental
- Price
- EH $16.16
- COGT $13.05
- Analyst Decision
- EH Strong Buy
- COGT Strong Buy
- Analyst Count
- EH 3
- COGT 11
- Target Price
- EH $24.80
- COGT $21.20
- AVG Volume (30 Days)
- EH 1.9M
- COGT 1.2M
- Earning Date
- EH 08-26-2025
- COGT 08-05-2025
- Dividend Yield
- EH N/A
- COGT N/A
- EPS Growth
- EH N/A
- COGT N/A
- EPS
- EH N/A
- COGT N/A
- Revenue
- EH $65,001,814.00
- COGT N/A
- Revenue This Year
- EH $102.39
- COGT N/A
- Revenue Next Year
- EH $59.66
- COGT N/A
- P/E Ratio
- EH N/A
- COGT N/A
- Revenue Growth
- EH 87.04
- COGT N/A
- 52 Week Low
- EH $11.35
- COGT $3.72
- 52 Week High
- EH $29.76
- COGT $13.50
- Technical
- Relative Strength Index (RSI)
- EH 41.11
- COGT 66.38
- Support Level
- EH $15.27
- COGT $11.87
- Resistance Level
- EH $19.00
- COGT $13.50
- Average True Range (ATR)
- EH 0.77
- COGT 0.55
- MACD
- EH -0.13
- COGT 0.05
- Stochastic Oscillator
- EH 23.86
- COGT 77.16
About EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.